Cargando…

EGFR Targeting TKI-Related Skin Toxicities in a Patient with Darker Skin: A Case Report

Epidermal growth factor receptor (EGFR) targeting tyrosine kinase inhibitors (TKIs) can result in significant skin toxicities that may impact patients’ quality of life. While these skin reactions are well documented in patients with lighter skin, there is a paucity of literature and images to guide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zereshkian, Arman, Thawer, Alia, Hwang, David M., Cheng, Susanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028593/ https://www.ncbi.nlm.nih.gov/pubmed/35448179 http://dx.doi.org/10.3390/curroncol29040205

Ejemplares similares

Lupus Vulgaris in Darker Skin: Dermoscopic and Histopathologic Incongruity
por: Ankad, Balachandra S., et al.
Publicado: (2020)

Melanoma: Does It Present Differently in Darker Skin Tones?
por: Thompson, Brandon, et al.
Publicado: (2023)

Absence of central white patch in dermatofibromas presenting in darker skin
por: Giddens, Tate, et al.
Publicado: (2022)

Assessing Healthcare Professionals’ Identification of Paediatric Dermatological Conditions in Darker Skin Tones
por: Shanmugavadivel, Dhurgshaarna, et al.
Publicado: (2022)

Butylparaben Exposure Induced Darker Skin Pigmentation in Nile Tilapia (Oreochromis niloticus)
por: Liu, Song, et al.
Publicado: (2023)

Palmar Basal Cell Carcinoma in Darker Skin Tone Patient: A Case Study
por: ALGHAMDI, Nada, et al.
Publicado: (2023)

Darker Skin Tone Increases Perceived Discrimination among Male but Not Female Caribbean Black Youth
por: Assari, Shervin, et al.
Publicado: (2017)

The Effect of Melasma on the Quality of Life in People with Darker Skin Types Living in Durban, South Africa
por: Mpofana, Nomakhosi, et al.
Publicado: (2023)

Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies
por: Giovannini, Monica, et al.
Publicado: (2009)

Skin rash caused by EGFR-TKI could be treated successfully by Pien Tze Huang Unguentum Compositum: a case report
por: Zhang, Mingzi, et al.
Publicado: (2022)

A Narrative Review of The Role of Foods as Dietary Sources of Vitamin D of Ethnic Minority Populations with Darker Skin: The Underestimated Challenge
por: Guo, Jing, et al.
Publicado: (2019)

Melasma in people with darker skin types: a scoping review protocol on prevalence, treatment options for melasma and impact on quality of life
por: Mpofana, Nomakhosi, et al.
Publicado: (2023)

The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy
por: Du, Ruofei, et al.
Publicado: (2022)

EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-Mutated NSCLC: A Prospective, Randomized, Exploratory Study
por: Gu, Weiguang, et al.
Publicado: (2023)

The darker vision of the Renaissance. Beyond the fields of reason
Publicado: (1976)

European mushroom assemblages are darker in cold climates
por: Krah, Franz-Sebastian, et al.
Publicado: (2019)

Super Vasmol Poisoning: Dangers of Darker Shade
por: Senthilkumaran, Subramanian, et al.
Publicado: (2019)

Black fungus, the darker side of COVID-19
por: Drissi, Cyrine
Publicado: (2021)

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer
por: Wang, Qiming, et al.
Publicado: (2019)

Identification of biomarkers, pathways, and therapeutic targets for EGFR–TKI resistance in NSCLC
por: Zhu, Leilei, et al.
Publicado: (2023)

Liver enzyme elevation and eosinophilia with atorvastatin: a case of probable DRESS without cutaneous symptoms
por: Zereshkian, Arman, et al.
Publicado: (2021)

Synergistic interaction between sorafenib and gemcitabine in EGFR-TKI-sensitive and EGFR-TKI-resistant human lung cancer cell lines
por: LI, JING, et al.
Publicado: (2013)

Glacier Algae: A Dark Past and a Darker Future
por: Williamson, Christopher J., et al.
Publicado: (2019)

EGFR/Met association regulates EGFR TKI resistance in breast cancer
por: Mueller, Kelly L, et al.
Publicado: (2010)

Vulvar and Vaginal Melanomas—The Darker Shades of Gynecological Cancers
por: Dobrică, Elena-Codruța, et al.
Publicado: (2021)

Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study
por: Wang, Wenxian, et al.
Publicado: (2019)

Home-based multidisciplinary interventions on skin adverse reactions in EGFR-TKI-treated patients with lung cancer: a protocol for a randomised controlled trial
por: Du, Ruofei, et al.
Publicado: (2022)

Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI
por: Xia, Guo-Hao, et al.
Publicado: (2014)

Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer
por: Cao, Peijun, et al.
Publicado: (2022)

Role of chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) rechallenge in small cell transformation after EGFR-TKI failure: a case report
por: Lee, Sanghun, et al.
Publicado: (2018)

Dermoscopic Features of Psoriasis, Lichen Planus, and Pityriasis Rosea in Patients With Skin Type IV and Darker Attending the Regional Dermatology Training Centre in Northern Tanzania
por: Nwako-Mohamadi, Maitseo K., et al.
Publicado: (2019)

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
por: Chung, Fu-Tsai, et al.
Publicado: (2015)

EGFR-TKI不良反应管理专家共识
Publicado: (2019)

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant
por: Zhao, Lihao, et al.
Publicado: (2019)

Heterogeneity of resistant mechanisms in an EGFR-TKI relapsed patient with EGFR amplification and response to nimotuzumab: A case report
por: Li, Yan, et al.
Publicado: (2022)

Mallory‐Weise syndrome in a patient treated with EGFR‐TKI
por: Okauchi, Shinichiro, et al.
Publicado: (2017)

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy
por: Gan, Jiadi, et al.
Publicado: (2021)

Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy
por: Lacouture, Mario E., et al.
Publicado: (2021)

Cool habitats support darker and bigger butterflies in Australian tropical forests
por: Xing, Shuang, et al.
Publicado: (2016)

The Significance of MMP-1 in EGFR-TKI–Resistant Lung Adenocarcinoma: Potential for Therapeutic Targeting
por: Saito, Ryoko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kpn6kulejdbbd5o189b0log50o